efavirenz has been researched along with Affective Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antunes, AM; Caixas, U; Correia, MJ; Diogo, LN; Grilo, NM; Harjivan, SG; Marques, MM; Monteiro, EC; Pereira, SA; Sequeira, C | 1 |
| Casado, JL; Corral, I; Dronda, F; Hernández, B; Moreno, A; Moreno, S; Pérez-Elías, MJ; Quereda, C; Rodríguez-Sagrado, MA | 1 |
| Delmas, B; Lochet, P; Lotthé, A; Mauboussin, JM; Peyrière, H; Reynes, J | 1 |
| Burger, D; Clotet, B; Ferrer, MJ; Fumaz, CR; Gómez, G; Moltó, J; Muñoz-Moreno, JA; Negredo, E; Pérez-Alvarez, N; Sirera, G | 1 |
| Bickel, M; Carlebach, A; Haberl, A; Kurowski, M; Rottmann, C; Staszewski, S; Stephan, C | 1 |
| Acosta, EP; Clifford, DB; Dorfman, D; Evans, S; Goodkin, K; Gulick, RM; Ribaudo, H; Simpson, D; Tashima, K; Yang, Y | 1 |
2 trial(s) available for efavirenz and Affective Disorders
| Article | Year |
|---|---|
Effect of treatment with efavirenz on neuropsychiatric adverse events of interferon in HIV/HCV-coinfected patients.
Topics: Alkynes; Anti-HIV Agents; Anxiety Disorders; Benzoxazines; Cyclopropanes; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Mental Disorders; Mood Disorders | 2008 |
Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; Female; HIV Infections; Humans; Male; Middle Aged; Mood Disorders; Oxazines; Prospective Studies; Reverse Transcriptase Inhibitors; Sleep Wake Disorders | 2005 |
5 other study(ies) available for efavirenz and Affective Disorders
| Article | Year |
|---|---|
Efavirenz biotransformation as an up-stream event of mood changes in HIV-infected patients.
Topics: Adult; Alkynes; Anti-HIV Agents; Anxiety; Benzoxazines; Biomarkers, Pharmacological; Biotransformation; Blood-Brain Barrier; Case-Control Studies; CD4 Lymphocyte Count; Cyclopropanes; Drug Monitoring; Drug Therapy, Combination; Feasibility Studies; Glucuronides; HIV Infections; Humans; Male; Metabolic Detoxication, Phase II; Middle Aged; Mood Disorders; Neurotoxicity Syndromes; Prevalence; Reverse Transcriptase Inhibitors | 2016 |
Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz.
Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Anxiety Disorders; Benzoxazines; Cognition Disorders; Cyclopropanes; Depressive Disorder; Female; Follow-Up Studies; HIV Infections; Humans; Male; Mental Disorders; Middle Aged; Mood Disorders; Oxazines; Quality of Life; Sleep Wake Disorders; Surveys and Questionnaires | 2003 |
Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Central Nervous System Diseases; Cognition Disorders; Cyclopropanes; Employment; Female; Humans; Male; Mood Disorders; Oxazines; Patient Compliance; Quality of Life; Retrospective Studies; Risk-Taking; Surveys and Questionnaires | 2005 |
Severe CNS side-effect and persistent high efavirenz plasma levels in a patient with HIV/HCV coinfection and liver cirrhosis.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; Female; Hepatitis C; HIV Infections; HIV-1; Humans; Liver Cirrhosis; Middle Aged; Mood Disorders; Mutation; Oxazines | 2005 |
Summaries for patients. Neuropsychological side effects of efavirenz.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; Female; HIV Infections; Humans; Male; Middle Aged; Mood Disorders; Oxazines; Prospective Studies; Reverse Transcriptase Inhibitors; Sleep Wake Disorders | 2005 |